Effect of implantable defibrillators on arrhythmic events and mortality in the multicenter unsustained tachycardia trial.
Open Access
- 9 July 2002
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 106 (2), 233-238
- https://doi.org/10.1161/01.cir.0000021920.73149.c3
Abstract
Background — The Multicenter Unsustained Tachycardia Trial (MUSTT) was designed to evaluate an antiarrhythmic treatment strategy, including drugs and implantable defibrillators (ICDs), guided by electrophysiological (EP) testing. We performed several statistical analyses to assess the contribution of defibrillators to the observed treatment benefit. Methods and Results — First, the effects of defibrillators were indirectly examined by comparing the randomized treatment arms (EP-guided therapy versus no antiarrhythmic therapy) within subgroups that varied according to ICD usage. Use of ICDs increased during the trial; hence, the randomized treatments were compared according to date of enrollment. There were also site-specific differences in ICD use; hence, the randomized arms were compared within groups of sites defined by level of ICD use. There was a distinct “dose response” in relation to ICD use. Where ICD use was high, EP-guided therapy produced significant reductions in arrhythmic death or cardiac arrest ( P 70% in arrhythmic death or cardiac arrest and >50% in total mortality ( P Conclusions — The benefit of EP-guided antiarrhythmic therapy observed in MUSTT was due to improved outcomes among patients who received an ICD but not among patients who received antiarrhythmic drugs.This publication has 11 references indexed in Scilit:
- Electrophysiologic Testing to Identify Patients with Coronary Artery Disease Who Are at Risk for Sudden DeathThe New England Journal of Medicine, 2000
- A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery DiseaseThe New England Journal of Medicine, 1999
- A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular ArrhythmiasThe New England Journal of Medicine, 1997
- Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular ArrhythmiaThe New England Journal of Medicine, 1996
- Prevention of sudden death in patients with coronary artery disease: The multicenter unsustained tachycardia trial (MUSTT)Progress in Cardiovascular Diseases, 1993
- A Comparison of Electrophysiologic Testing with Holter Monitoring to Predict Antiarrhythmic-Drug Efficacy for Ventricular TachyarrhythmiasThe New England Journal of Medicine, 1993
- A Comparison of Electrophysiologically Guided Antiarrhythmic Drug Therapy with Beta-Blocker Therapy in Patients with Symptomatic, Sustained Ventricular TachyarrhythmiasThe New England Journal of Medicine, 1992
- Drug therapy for ventricular tachyarrhythmias: How many electropharmacologic trials are appropriate?Journal of the American College of Cardiology, 1991
- Reappraisal of criteria for assessing drug efficacy in patients with ventricular tachyarrhythmias: Complete versus partial suppression of inducible arrhythmiasJournal of the American College of Cardiology, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958